GlassScriptPhysician profile
Timothy J Miller
NPI 1013175900
$37,326.16
in general payments reported to CMS, 2019-2025
31 companies · $19K in 2025
The $19K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,895 · 2020: $163 · 2021: $241 · 2022: $1,145 · 2023: $121 · 2024: $15K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $9,037 · Food and Beverage: $1,687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,158.11 |
| Travel and Lodging | $9,036.70 |
| Food and Beverage | $1,687.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $25,304.79 | 2023-2025 | Biobrace 23mm, Quantum, Ibs |
| Treace Medical Concepts, INC. | $7,719.05 | 2024-2025 | |
| Wright Medical Technology, INC. | $1,649.33 | 2019 | |
| Mml US, INC. | $934.70 | 2022 | |
| Stryker Corporation | $465.45 | 2019-2025 | Mako, Pangea, Tornier Perform Reversed Glenoid |
| Ethicon INC. | $140.65 | 2024 | |
| Acumed LLC | $116.00 | 2022-2024 | Acumed |
| Abiomed | $103.19 | 2021 | |
| Si-Bone, INC. | $102.40 | 2019 | |
| Ossio INC | $99.25 | 2022 | |
| Biocomposites INC | $89.74 | 2020 | |
| Djo, LLC | $75.24 | 2024 | Procare |
| Bioventus LLC | $74.75 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Integra Lifesciences Corporation | $43.66 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Pacira Therapeutics, INC. | $43.33 | 2019-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $31.70 | 2022 | |
| Ferring Pharmaceuticals INC. | $31.15 | 2021 | |
| Zimmer Biomet Holdings, INC. | $31.11 | 2019 | |
| Depuy Synthes Sales INC. | $30.95 | 2022-2023 | Orthovisc |
| Painteq LLC | $30.54 | 2024 | Painteq |
| Innovation Technologies INC | $27.60 | 2021 | |
| Redhill Biopharma INC. | $26.08 | 2020 | |
| Fx Shoulder Solutions, INC | $22.96 | 2019 | |
| Genmab U.S., INC. | $21.89 | 2024 | Epkinly |
| Kci USA, INC. | $21.84 | 2020 | |
| Vericel Corporation | $19.12 | 2019 | |
| Anika Therapeutics, INC. | $16.62 | 2021 | |
| Davol INC. | $14.41 | 2021 | |
| Amgen INC. | $13.53 | 2025 | Krystexxa |
| Abbott Laboratories | $13.34 | 2021 | |
| Baudax Bio INC. | $11.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.